-
Functional Role of COP1 Gene in Hepatocellular Carcinoma Lipid Metabolism and Stemness
Jeon EH, Bae AN, Lee H, Park KU, Shin HM, Park JH, Kim KS, Park IC
Genes to Cells, 2026. 5. 1.
-
Ribosomal Protein L9 Maintains Stemness of Colorectal Cancer via an ID-1 Dependent Mechanism
Jeon EH, Park SY, Park KU, Lee YH
Journal of Cancer Prevention, 2024. 6. 30.
-
RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling
Park SY, Seo D, Jeon EH, Park JY, Jang BC, Kim JI, Im SS, Lee JH, Kim S, Cho CH, Lee YH
International Journal of Oncology, 2023. 8. 1.
-
RPL17 promotes colorectal cancer proliferation and stemness through ERK and NEK2/β-catenin signaling pathways
Ko MJ, Seo YR, Seo D, Park SY, Seo JH, Jeon EH, Kim SW, Park KU, Koo DB, Kim S, Bae JH, Song DK, Cho CH, Kim KS, Lee YH
Journal of Cancer, 2022. 5. 13.
-
Silencing CDCA8 suppresses hepatocellular carcinoma growth and stemness via restoration of ATF3 tumor suppressor and inactivation of AKT/β–Catenin signaling
Jeon T, Ko MJ, Seo YR, Jung SJ, Seo D, Park SY, Park KU, Kim KS, Kim M, Seo JH, Park IC, Kim MJ, Bae JH, Song DK, Cho CH, Lee JH, Lee YH
Cancers, 2021. 3. 2.
-
Targeting CALM2 inhibits hepatocellular carcinoma growth and metastasis by suppressing E2F5-mediated cell cycle progression
Park SY, Seo YR, Ko MJ, Lee JH, Chun KS, Kim MJ, Choo YK, Lee TJ, Lee YH
Anticancer Research, 2021. 3. 2.
-
Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-κB signaling axis
Baik IH, Jo GH, Seo D, Ko MJ, Cho CH, Lee MG, Lee YH
International Journal of Oncology, 2016. 11. 1
-
Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma
Choi Y, Oh ST, Won MA, Choi KM, Ko MJ, Seo D, Jeon TW, Baik IH, Ye SK, Park KU, Park IC, Jang BC, Seo JY, Lee YH
Biochem Biophys Res Commun, 2026. 11. 1
-
STAT3-mediated CD133 upregulation contributes to promotion of hepatocellular carcinoma
Won CH, Kim BH, Yi EH, Choi KJ, Kim EK, Jeong JM, Lee JH, Ja-Jang JJ, Yoon JH, Jeong WI, Park IC, Kim TW, Bae SS, Factor VM, Ma S, Thorgeirsson SS, Lee YH, Ye SK
Hepatology, 2015. 10. 1
-
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2
Lee YH, Seo D, Choi KJ, Andersen JB, Won MA, Kitade M, Gomez-Quiroz LE, Judge AD, Marquardt JU, Raggi C, Conner EA, MacLachlan I, Factor VM, Thorgeirsson SS
Cancer Research, 2014. 9. 1
-
Molecular targeting of CSN5 in human hepatocellular carcinoma: A mechanism of therapeutic response.
Lee YH, Judge AD, Seo D, Kitade M, Gomez-Quiroz LE, Ishikawa T, Andersen JB, Kim BK, Marquardt JU, Raggi C, Avital I, Conner EA, MacLachlan I, Factor VM, Thorgeirsson SS
Oncogene, 2011. 4. 18
-
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma
Lee YH, Andersen JB, Song HT, Judge AD, Seo D, Ishikawa T, Marquardt JU, Kitade M, Durkin M, Raggi C, Woo HG, Conner EA, Avital I, MacLachlan I, Factor VM, Thorgeirsson SS
Cancer Research, 2010. 11. 1
-
Gene knockdown by large circular antisense for high-throughput functional genomics
Lee YH, Moon IJ, Hur B, Park JH, Han KH, Uhm SY, Kim YJ, Kang KJ, Park JW, Seu YB, Kim YH, Park JG
Nature Biotechnology, 2005. 5. 1
